Application of a revised model for coping with advanced cancer to qualitatively explore lung cancer survivors' experiences of ongoing physical effects, novel treatments, uncertainty, and coping

被引:7
作者
Laidsaar-Powell, Rebekah [1 ]
Butow, Phyllis [1 ]
Brown, Bernadette Bea [2 ]
Mander, Kimberley [2 ]
Young, Jane [3 ,4 ]
Stone, Emily [3 ,5 ,6 ]
Chin, Venessa [6 ,7 ,8 ]
Banks, Emily [9 ]
Lim, Chloe Yi Shing [1 ]
Rankin, Nicole M. [10 ]
机构
[1] Univ Sydney, Fac Sci, Ctr Med Psychol & Evidence Based Decis Making CeM, Sch Psychol, Sydney, NSW, Australia
[2] Univ Sydney, Fac Med & Hlth, NHMRC Clin Trials Ctr, Sydney, NSW, Australia
[3] Univ Sydney, Fac Med & Hlth, Sydney Sch Publ Hlth, Sydney, NSW, Australia
[4] Univ Sydney, Daffodil Ctr, Sydney, NSW, Australia
[5] St Vincents Hosp Sydney, Dept Thorac Med & Lung Transplantat, Sydney, Australia
[6] UNSW, Sch Clin Med, Sydney, Australia
[7] Kinghorn Canc Ctr, 370 Victoria St, Sydney, NSW 2010, Australia
[8] Garvan Inst Med Res, Sydney, NSW, Australia
[9] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia
[10] Univ Melbourne, Ctr Hlth Policy, Melbourne Sch Populat & Global Hlth, Melbourne, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
Lung cancer; Survivorship; Qualitative; Immunotherapy; Coping and adjustment; QUALITY-OF-LIFE; SMOKING; FACE;
D O I
10.1007/s11764-023-01417-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeLung cancer remains underrepresented in cancer survivorship research. This study aimed to understand survivors' physical/psychological challenges, experiences of immunotherapy (IO) and targeted therapy (TT), and psychological adjustment through application of the Roberts et al. (2017) advanced cancer adaptation of Folkman and Greer's appraisal and coping model.MethodsAdults 6-24 months post-initial treatment completion were recruited via an Australian cohort study. Participant demographic, clinical, quality of life, and distress data were obtained through the cohort database. Qualitative interviews were conducted and analyzed using Framework methods. Roberts et al. (2017)'s model informed data interpretation and presentation.ResultsTwenty interviews were conducted (10 females; average age 69 years). Participants' diagnostic stages varied (stage I = 2, stage II = 4, stage III = 8, stage IV = 6); most had received IO/TT (n = 14) and were on average 17 months (range 10-24) post-diagnosis. Three themes were identified and mapped to the Roberts' framework: (1) Ongoing illness events: most participants reported functioning well despite ongoing physical effects. Those on IO/TT reported side effects; some were unexpected/serious. (2) Adjusting to life with lung cancer: most expressed hope for the future while simultaneously preparing for disease progression. Those receiving IO/TT experienced uncertainty given limited survival information. (3) Learning to live with lung cancer: participants described emotion, problem, and meaning based on coping strategies.ConclusionsFindings may guide development of supportive care resources/interventions focused on uncertainty, IO/TT communication and decision-making, and coping.Implications for Cancer SurvivorsMany people with lung cancer are living well with their ongoing illness. Despite challenges, many survivors are adapting to issues as they arise and are maintaining a sense of hope and optimism.
引用
收藏
页码:1754 / 1770
页数:17
相关论文
共 37 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]   Lung cancer: progress with prognosis and the changing state of play [J].
Brims, Fraser J. ;
McWilliams, Annette ;
Harden, Susan V. ;
O'Byrne, Ken .
MEDICAL JOURNAL OF AUSTRALIA, 2022, 216 (07) :334-336
[3]   Complex challenges for patients with protracted incurable cancer: an ethnographic study in a comprehensive cancer centre in the Netherlands [J].
Buiting, Hilde M. ;
van Ark, Marleen A. C. ;
Dethmers, Otto ;
Maats, Emma P. E. ;
Stoker, Jogien A. ;
Sonke, Gabe S. .
BMJ OPEN, 2019, 9 (03)
[4]   Markers of the denormalisation of smoking and the tobacco industry [J].
Chapman, S. ;
Freeman, B. .
TOBACCO CONTROL, 2008, 17 (01) :25-31
[5]   A qualitative study of healthcare-related experiences of non-smoking women with lung cancer [J].
Dao, Dyda ;
O'Connor, Jennifer M. ;
Jatoi, Aminah ;
Ridgeway, Jennifer ;
Deering, Erin ;
Schwecke, Anna ;
Breitkopf, Carmen Radecki ;
Huston, Olivia ;
Le-Rademacher, Jennifer G. .
SUPPORTIVE CARE IN CANCER, 2020, 28 (01) :123-130
[6]   The Changing Face of Lung Cancer: Survivor Perspectives on Patient Engagement [J].
Fitch, Margaret I. .
ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2019, 6 (01) :17-23
[7]  
Folkman S, 2000, PSYCHO-ONCOL, V9, P11, DOI 10.1002/(SICI)1099-1611(200001/02)9:1<11::AID-PON424>3.3.CO
[8]  
2-Q
[9]  
Greenhalgh EM., 2023, Tobacco in Australia: Facts and issues
[10]   Development of the Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator (FACT-ICM): A toxicity subscale to measure quality of life in patients with cancer who are treated with ICMs [J].
Hansen, Aaron R. ;
Ala-Leppilampi, Kari ;
McKillop, Chris ;
Siu, Lillian L. ;
Bedard, Philippe L. ;
Razak, Albiruni R. Abdul ;
Spreafico, Anna ;
Sridhar, Srikala S. ;
Leighl, Natasha ;
Butler, Marcus O. ;
Hogg, David ;
Sacher, Adrian ;
Oza, Amit M. ;
Al-Agha, Rany ;
Maurice, Catherine ;
Chan, Christopher T. ;
Shapera, Shane ;
Feld, Jordan J. ;
Nisenbaum, Rosane ;
Webster, Kimberly ;
Cella, David ;
Parsons, Janet .
CANCER, 2020, 126 (07) :1550-1558